000 01476 a2200373 4500
005 20250513170557.0
264 0 _c19990407
008 199904s 0 0 eng d
022 _a0957-5235
024 7 _a10.1097/00001721-199901000-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScaraggi, F A
245 0 0 _aTreatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.
_h[electronic resource]
260 _bBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
_cJan 1999
300 _a33-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies
_xblood
650 0 4 _aFactor VIIa
_xadministration & dosage
650 0 4 _aHemophilia A
_xblood
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aInjections, Intravenous
650 0 4 _aMale
650 0 4 _aRecombinant Proteins
_xadministration & dosage
700 1 _aDe Mitrio, V
700 1 _aMarino, R
700 1 _aSpeciale, V
700 1 _aDi Bari, L
700 1 _aPetronelli, M
700 1 _aSchiraldi, O
773 0 _tBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
_gvol. 10
_gno. 1
_gp. 33-8
856 4 0 _uhttps://doi.org/10.1097/00001721-199901000-00005
_zAvailable from publisher's website
999 _c10030834
_d10030834